175
Views
20
CrossRef citations to date
0
Altmetric
Review

Strategies for DNA vaccine delivery

, &
Pages 829-842 | Published online: 16 Sep 2005

Bibliography

  • HILLEMAN MR: Vaxinesin historic evolution aid perspective a na-rativeof vaxinediaoveri es Vacci ne (2000) 18(15):1436–1447.
  • ••MauriceHillemai died in April 2005.H is contri buti on to the development aid implementation of vaxi nes issummaised in a recent profile i n Nature Mali ci ne (2005) 11(4 aippl.):S2.
  • KAPLAN C: Syrnpad um on and I pox eralicetion. analpox eradicetion-a na-rati ve amount. Trans R Szo Trcp. Med. Hg (1975) 69(3):293–298.
  • MAKELA PH: Vaxi nes coming of age after 200 yeers FEMS M (rod d. Re/. (2000) 24(1):9–20.
  • WAREING MD, TANNOCK GA: Live attenuaed vaxi nes aga nst influenza ai historica review. Vaccine(2001) 19(25-26):3320–3330.
  • FLETCHER MA, SALIOU P,ETHEVENAUX C, PLOTKIN SA: T he effi cacy of whole oell pertuais immunisation: collected daaon a vaxi ne produced in Fraice Public Health (2001) 115(2):119–129.
  • GALAZKA A: Control of pertuais in theworld. VVcrld Health Sat. Q (1992) 45(2-3):238–247.
  • MCALEERW J, BUYNAK EB, MAIGETTER RZ, WAMPLER DE, MILLER WJ, HILLEMAN MR:Humai hepaitisB vaminefrom recombi nal yeast. Nature (1984) 307(5947):178–180.
  • EDINA A, RUTTER WJ, MERER G, HALL BD: Synthed s aid assembly of hepaitisB virus airfacealigen pa-tides in yeast. Nature (1982) 298(5872):347–350.
  • LILJEQVIST S, STAHL S R-oduction of rmbinait athunit vaxi nes protein immunogens live delivery syaemsaid nudeic acid vanes Biotechnd. (1999) 73(1):1–33.
  • TANNER M, TEUSCHER T, ALONSO PL: SPf66 - Thefird ma ai a vaocine Pa-asi td Tcday (1995) 11(1):10–13.
  • ALPAR HO, BRAMWELL VW: Currentus of DNA vaxi nes aid their route of administration. Crit. Rat. The-. Drug Carrie- Syd. (2002) 19(4-5):307–383.
  • •M ore deta led diaussion in the a-eas of vaxi ne aid DNA vaxi ne development.
  • MACKENZIE D: Down but not out. Nay Sd. (2000) 2224:20.
  • HILLEMAN MR: Diaovery of dmiai virus40 (S/40) aid itsrelaionthip to poliomyelitisvirusvaxines Da. Bid. Sand. (1998) 94:183–190.
  • MEET BH, HILLEMAN MR: T he vacuolati ng virus SV. 40. Rco Szo Exp. Bid. Med. (1960) 105:420–427.
  • BRAMWELL VW, OYAALPAR H: Pati cul ate delivery systems for biodefenaibunit vaxi nes Adv. Drug Div. Re/. (2005) 57(9):1247–1265.
  • BRAMWELL VW, PERRIE Y: Paticulatedivffy syst EMS for vaxi nes Crit. Rev The-. Drug Carrie- Sid. (2005) 22(2):151–214.
  • •Perspective on paticulate aid aibunit vaDoi ne development, aid case study for their potentia in tuberculosis aid IV vaxi nes
  • LECLERC C: New approaches n vaxine development. Ca-np. I mmund Micrcbid. (2003) 26(5-6):329–341.
  • X B, HASSANI Z, BEHR JR: Towa-dsmultifunctiond synthetic vectors Curr. GaieThe-. (2004) 4(4):445–455.
  • WOLFF JA, MALONE RW, WILLIAM SP et al.: Direct gene traisfer into mou musde in vivo. Sience(1990) 247(4949 Pt 1):1465–1468.
  • TANG DC, DEVIT M, JOHNSTON SA: Genetic immunization is a d mple method for eliciting ai immunereeponm Nature (1992) 356(6365):152–154.
  • DAVIS HL, MCCLUSKIE MJ: DNA vaxinesfor vird diseases MicrcassInfed (1999) 1(1):7–21.
  • TAKESHITA F, XIN KQ,ISHINI N, OKUDA K: Adjuvait formulaionsaid delivery systemsfor DNA \taxi nes Methcds(2003) 31(3):243–254.
  • EGAN MA, ISRAEL ZR: T he of cytokinesaid chemokinesasgenetic adjuvalsfor plasmid DNA vaxi nes Clini aid Applied I mmundcgy ays(2002) 2(4–5):255–287.
  • LI G, KONG Y, WANG Y: Expression aid cha-acteri zati on of chimeric hepaitisB airfaceali gen patidesca-rying preS epi topesJ Biotehnd. (1999) 72(1-2):49–59.
  • SCHIRMBECK R, ZHENG X, ROGGEN DORF M et al.: Ta-geting murine immune responses to SEI ected T celI- or aiti body-defined determi naits of the hepaitisB airfacealigen by plasmid DNA vaxinesencoding chimeric aligen. I mmund . (2001) 166(2):1405–1413.
  • FYNAN EF, WEBSTER RG, FULLER DH, HAYNES JR, SANTORO JC, ROBINSON HL: DNA vaccines a novel approach to immunization. Int J I mmuncpharm (1995) 17(2):79–83.
  • ADAMS MM, VAN LEEUWEN BH, KERR PJ: Limitati ons of plasmid vaocines to complex viruses selected myxoma virus aligens as D NA vaxineswere not protective Vacci ne (2004) 23(2): 198–204.
  • DONNELLY J, BERRY K, ULMER JB: Technical aid regulaory hurdlesfor DNA vaccines Int. J Paradtd. (2003) 33(5-6):457–467.
  • MCMAHON JM, WELLS DJ. Electroporation for gene trader to dcel eta MUS3I ES current status BicDru(2004) 18(3):155–165.
  • MONTGOMERY DL, DONNELLY JJ, SIHIVER JW, LIU MA, ULMER JB: R-otein expression in vivo by injection of polynudeotides Curr. Opi n. Biotech. (1994) 5(5):505–510.
  • RAMAKRISHNA L, ANAND KK, MAHALINGAM M et al.: Codon optimization aid ubiquitin conjugaion of humai immunodeficiency virus-1 Ta Ii to enhaiced ceil-mediaed immune responses Vaccine(2004) 22(20):2586–2598.
  • •Codon optimisation is al interesting strategy for vira genes a though viruses have evolved to express thei r proteins in manma ai systems control of expression by subopti ma codon usage i s a common mechaii sm for the control of protein expression by viruses
  • STEMMER WP: Rapid evolution of a protein in vitro by DNA thuffling. Nature (1994) 370(6488):389–391.
  • •Sgnifical increases in protein function were reported by raidorn fragmentation aid polymerasechen reaction reassembly.
  • CRAMERI A, WHITEHORN EA, TATE E, STEMMER WPC: I mproved green fluores:ent protein by molecula evolution udng DNA thuffling. Nat. Bide:h. (1996) 14(3):315–319.
  • CHANG CC, CHEN TT, COX BW et a.: Evolution of a cytoki ne udng DNA fa-nily thuffling. Nat. Biotahnd. (1999) 17(8):793–797.
  • TOBIN MB, GUSTAFSSON C, HUISMAN GW: Directed evolution: the 'rati ona' bad sfor 'irrationa' design. Curr. Opin. arud. Bid. (2000) 10(4):421–427.
  • PASQUINI S, XIANG Z,WANG Y etal.: Cytokines aid costimulaory molecules as genetic adjuvals I mmund. Cell Bid. (1997) 75(4):397–401.
  • VARNAVSKI AN, KHROMYKH AA: N oncytopathic flavivi rus repl icon RNA-basal system for expression aid delivery of heterologous genes Vi rdcgy (1999) 255(2):366–375.
  • YING H, ZAKS TZ, WANG RF et al.: Caioer therapy udng a salf-repl caing RNA vaocine Nat. Med. (1999) 5(7):823–827.
  • ••SEM i nd paper for self-replicating RNAvectors as vaxi nes
  • DUBENSKYTW JR, DRIVER DA, POLO JM et al.: Sindbisvi rus D NA-basecl expression vectors utility for in vitro aid in vivogenetraisfer. J Vird. (1996) 70(1):508–519.
  • HARIHARAN MJ, DRIVER DA, TOWNSEND K et al.: DNA immunization aid an herpesdmplex virus enhaicecl efficacy udng a dndbi s vi rus-based vector. J Vi rd. (1998) 72(2):950–958.
  • VARNAVSKI AN, YOUNG PR, KHROMYKH AA: Sailehigh-level expreesi on of heterologousgenesin vitro aid in vivo by noncytopahic DNA-based kunjin vi rus repl i con vectors J Vird. (2000) 74(9):4394–4403.
  • LODMELL DL, RAY NB, ULRICH JT, EWALT LC: DNA vaxi nation of mice anst rapiesvirus effects of the route of vaocinaion aid the adj uval monophoThoryl lipid A (MPL(R)). Vaccine(2000) 18(11-12):1059–1066.
  • ZUBER AK, BRAVE A, ENGSTROM G et al.: Topical delivery of imiquimod to a moumodel asanovel adj uvait for humai immunoclefidency virus (H IV) DNA Vaccine(2004) 22(13–14):1791–1798.
  • HAGAN DT, SINGH M, ULMER JB: Micropatidesfor the delivery of DNA vaxines I mmund. Rev. (2004) 199(1):191–200.
  • KIM BM, LEEDS, CHOIJH etal.: In vivo kineticsaid biodistribution of a H IV-1 DNA vaxineafter adminiaraion in mice Arch. Pharm. RES (2003) 26(6):493–498.
  • ALPAR HO, SOMAVARAPU S, ATUAH KN, BRAMWELL VW: Biodegradaile mucoalhedvepaticulates for n aid pulmonay aligen aid DNA delivery. Adv. Drug Deli ve-. Rev. (2005) 57(3):411–430.
  • DEAN HJ, FULLER D, OSORIO JE: Fbwder aid patide-mediaecl approaches for delivery of DNA aid protein vanes into the epidermis Ccmp. I mmund Micrcb. (2003) 26(5-6):373–388.
  • JIANG W, GUPTA RK, DESHPANDE MC, SCHWENDEMAN SR Biodegradaile poly(lactic-co-glycolic acid) micropatides for i njectaile del i very of vaxineaitigeis Adv. Drug Deliver. Rat. (2005) 57(3):391–410.
  • TAMBER H, JOHANSEN P, MERKLE HP, GANDER B: Formulation aTectsof biodegradaile polymeric micraTheresfor all gen delivery. Adv. Drug Deily. Rev. (2005) 57(3):357–376.
  • LANGER R, FOLKMAN J Fblymersfor the aide nal reiease of protei ns aid other macromolecules Nature(1976) 263(5580):797–800.
  • PREIS I, LANGER RS: A dngle-dep immunization by sista ned aiti gen release J. I mmund Methcds(1979) 28(1-2):193–197.
  • JILEK S, MERKLE HP, WALTER E: DNA-loaded biodegradailemicropatides ffi vaocine del ivery sydemsaid their interaction with dendritic cells Adv. Drug Del i ve-. Rev (2005) 57(3):377–390.
  • WALTER E, MOELLING K, PAVLOVIC J, MERKLE HP: M icroencamlati on of DNA udng poly(-lactide-co-gycolide): dapility issuesaid release cha-acteri stics J. Ccntrd. Rdeas (1999) 61(3):361–374.
  • ANDERSON JM, SHIVE MS: Biodegradaion aid biocompatibility of PLA aid PLGA microTheres Adv. Drug Deliver. Rat. (1997) 28(1):5–24.
  • GOPFERICH A: Maiaiiiisofpolyme degradation aid erod on. Bicmate-ials (1996) 17(2):103–114.
  • COHEN SR, HOLMES RE, MELTZER HS, LEVY ML, BECKETT MZ: Craiiofacia recondruction with a fast resxbing polymer: a6- to 12-month dinicd follow-up review. Neurceurg Foals (2004) 16(3):E12.
  • VACCARO AR, SINGH K, HAID R et al.: The ua of biodosorbdoleimplaitsin the TineneJ. (2003) 3(3):227–237.
  • WEBB AR, YANG J, EER GA: Biodegraidolepolyester elastomers in tissue engineering. Expert Olin. Bid. The-. (2004) 4(6):801–812.
  • FESSI H, PUISIEUX F, DEVISSAGUET JP, AMMOURY N, BENITA S: N alocepaile formai on by interfacid polymer depodtion following solvent di Tlacement. Int. J. Pharm. (1989) 55(1):R1–R4.
  • ALLEMANN E, GURNY R, DOELKER E: Ftepa-ation of aqueous polyrneric nalodidoerdons by a reverdble siting-out process i nfl uence of process pa-a-neters on pa-tide d Int. d Pham. (1992) 87(1-3):247–253.
  • CHOI SW, KWON HY, KIM JH: Thermoclyna-nic pa-aneters on poly(laotide-co-glycolide) patidedzein emuldfication-diffudon process Cdlcid awfaceA (2002) 201(1–3):283–289.
  • NYKAMP G, CARSTENSEN U, MULLER BW: Jet milling-anew technique for mi cropati de prepa-ation. Int. J. Pham. (2002) 242(1-2):79–86.
  • FLORENCE AT, WHITEHILL D: Theformulation aid stdoi Iffy of multiple emuldons Int. d Pharm. (1982) 11(4):277–308.
  • JONES DH, CORRIS S, MCDONALD S, CLEGG JCS, FARRAR GH: Fbly(-1aotide-co-glycolide)-encepa1lated pl amid DNA idts sistemic aid mucosi all body reeponsas to Encoded protein Oter or alministraion. Vaccine(1997) 15(8):814–817.
  • JILEK S, WALTER E, MERKLE HP, CORTHESY B: Modulaion of dlergic reeponsasin mice by udng biodegraidole pol y(laoti de-co-glycol ide) microTheres J. Al I e-gy Olin. I mmund. (2004) 114(4):943–950.
  • BANGHAM AD, STANDISH MM, WATKINS JC: Diffudon of univdent ionsacrossthe la-nella of swollen phodoholipids J. Md. Bid. (1965) 13(1):238–252.
  • SESSA G, WEISSMANN G: Phodohol i pi d Therul es (I posomes) a a model for biolojcei membraies J. Lipid Res (1968) 9(3):310–318.
  • ALLISON AG, GREGORIADIS G: Li posomes i mmunologicel aljuvals Nature (1974) 252(5480):252.
  • LASIC DD, PAPAHADJOPOULOS D: Li posomes revid ted. eice(1995) 267(5202):1275–1276.
  • KIRBY CJ, GREGORIADIS G: Ftepa-aion of liposomescontdning Faotor VIII for or treatment of haemophilia M acencepeul . (1984) 1(1):33–45.
  • S G, MCCORMACK B, 0 OVIC M, E R, I B, PERRI EY: Vaod ne entrapment in liposomes Methcds(1999) 19(1):156–162.
  • PERRIE Y, GREGORIADIS G: Li posome-plamid DNA: cha-aoteristion studies Bicchim. Biophys Ada (BBA)- General ailojeds (2000) 1475(2):125–132.
  • PERRIE Y, FREDERIK PM, GREGORIADIS G: Liposome-mediated DNA vaxinaion: theeffect of vedde composition. Vaccine(2001) 19(23-24):3301–3310.
  • LI J, HUANG Y, LIANG X et al.: Plamid DNA Encodi ng aligensof infectiousbursi dissasevi ruses induce protective immune reeponsesin chickens faotorsinfluencing efficacy. Vi rus Res (2003) 98(1):63–74.
  • FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly effident, lipid-mediaed DNA-tradection procedure Rm. Natl. Acad. Si. USA (1987) 84(21):7413–7417.
  • PRASAD TK, GOPAL V, RAO N: Strudurd chagesin DNA mediated by caionic pids ate- in vitro traisoriptiond activity a low cha-ge ratios Bicchim. Bicphys Ada (BBA) -Gaiff allojeds(2003) 1619(1):59–69.
  • GAO X, HUANG L: A novel cetionic I i posome reagent for effident tradection of manmdial cells Bicchem. Bicph. Res Ca (1991) 179(1):280–285.
  • I LS, GAGNE L, URSTON G, FC JR: Mechaiian of li poplex genedelivery in moua lung: binding aid interndization of fluoracent lipid aid DNA components GeneTher. (2001) 8(11):828–836.
  • WANG D, CHRISTOPHER ME, NAGATA LP et al.: I ntraial immunization with liposome-encepailated plas-nid DNA encoding influenzavirus hemajglutinin icits mucosi, clula aid humor d immune reeponsesJ Olin. Vi rd . (2004) 31(aippl. 1):99–106.
  • WONG JP, ZABIELSKI MA, SCHMALTZ FL et d.: DNA vaxination ajdnst reepiratory influenza vi rusinfection. Vacci ne (2001) 19(17–19):2461–2467.
  • YOSHIKAWA T, IMAZU S, GAO JQ et al.: Augmentaion of aligen-Tecific immune reeponses udng DNA-fusxjenic I i posome vaxi ne Bicchem. Bioph. RES CQ (2004) 325(2):500–505.
  • KLAVINSKIS LS, GAO L, BARNFlELD C, LEHNER T, PARKER S: Mucoal immunization with DNA-li posome complexes Vaai ne (1997) 15(8):818–820.
  • NAKANISHI T, KUNISAWA J, HAYASHI A et al.: Ridtively chaged liposomefunctionsasai efficient immunoadjuval in inducing cell-mediated immune reeponato SD luble proteins Ccntrd. Re( 1999) 61(1-2):233–240.
  • YASUDA K, OGAWA Y, KISHIMOTO M, TAKAGI T, HASHIDA M, TAKAKURA Y: Plamid DNA activaesmurinemacrophajesto induceinflanmatory cytokinesin a CpG motif-independent mainer by complex formai on with cetioni c I i posomes Bicchem. Bicphys Res Ccmmun. (2002) 293(1):344–348.
  • ALMEIDA J, EDWARDS DC, BRAND C, HEATH T: Formation of virosomesfrom influenza al buni ts aid I i posomes Lancet (1975) 306(7941):899–901.
  • CUSI MG, TERROSI C, SWELLINI GG, GENOVA GD, ZURBRIGGEN R, CORREALE P: Effident delivery of DNA to dendritic cel Is mediaed by influenza virosomes Vacci ne (2004) 22(5–6):736–740.
  • CUSI MG, VECCHIO MT, TERROSI C et al.: Immune-reconstituted influenzavirosomecontdning CD4OL gene enhaioesthe mmunologicei aid protective activity of a ca-ci noembryoni c aligen alicalcer vaxine J I mmund (2005) 174(11):7210–7216.
  • KUNISAWA J, MASUDA T, KATAYAMA K et al.: Fusocjenicliposome del i vers en CE4Dallaed nampa-ti des for cytosol c controlled gene ref Elsa Ccntrd. Releaa (I n pre).
  • GEBREKIDAN S, WOO BH, DELUCA PP Formulaion aid in vitro traisfecti on efficiency of poly (0, L-laoti de-co-g ycol ide) microTherescontdning pl amid DNA for gene delivery. AAPS Pharmai Tech (2000) 1(4):E28.
  • VANDERVOORT J, LUDWIG A: Biowmpaiblestdoilizersin the prepa-ation of PLGA nalopa-tides afxtorid dedgn study. Int. d Pham. (2002) 238(1-2):77–92.
  • TINSLEY-BOWN AM, FRETWELL R, DOWSETT AB, DAVIS SL, FARRAR GH : Formulation of poly(-lic-co-glycol ic acid) micropa-tidesfor rapid plasmid DNA delivery. d Ccntrd. Re.% (2000) 66(2-3):229–241.
  • HERNANDEZ-CASELLES T, VILLALAIN J, GOMEZ-FERNANDEZ JC: I nfluence of lipommecha-gead compodtion on their interaction with humai blood Se r um proteins Md. Cell. Bicchen. (1993) 120(2):119–126.
  • ILARDUYA C, DUZGUNES N : Effident gene traisfer by traisferrin lipoplexesin the presence of serum. Bicchim. Biophys Ada (BBA)-Bicmembranes(2000) 1463(2):333–342.
  • HUANG L: Overcoming the inhibitory effect of serum on I ipofection by increasing the chage ratio of cationic lipospmeto DNA. GeleThe-. (1997) 4(9):950–960.
  • ATUAH KN, WALTER E, MERKLE HP, ALPAR HO: Encepaildi on of plaemid DNA in PLGA-steerylaninemicroTheres a compaism of SD !vent evdpordi on aid Tray-drying methods J Micrceicapsul. (2003) 20(3):387–399.
  • KUMAR MNV, BAKOWSKY U, LEHR CM: Prepadion aid chaacterizdi on of cdionic PLGA naloTheresffi DNA caters Bicmate-ials(2004) 25(10):1771–1777.
  • SINGH M, BRIONES M, OTT G, O'HAGAN D: Cdionic micropatides a potent delivery sydem for DNA vamines Froa Natl. Acad. ai. USA (2000) 97(2):811–816.
  • DAWNSON M, KRAULAND E, WIRTZ D, HANES J. TraiTort of polymeric nampatidegenecariersin gastric mucus Bide:hnd. Prcg (2004) 20(3):851–857.
  • CAPAN Y, WOO BH, GEBREKIDAN S, AHMED S, DELUCA PP: I nfluence of formulation paaneterson the chaacteri cs of poly(-Ixti de-co-glycol ide) microTherescontdning poly(-Iydne) complexed plas-nid DNA d Ccntrd. Release(1999) 60(2-3):279–286.
  • BRAMWELL VW, EYLES, ALPAR HO: Lipomme/D NA comple(escodecl with biodegraddolePLA improve immune responses to plaemid Encoding hepditisB airfacealigen. I mmundcgy (2002) 106(3):412–418.
  • ISHII N, OKADA E et al.: H IV-1-Tecific cell-mediated immune responsesinduoed by DNA vaccination were enhaiced by mama-I-coated I ipommes aid inhibited bynterferon-ga-nma aiti body I mmundcgy (1997) 92(1):111–117.
  • HOWARD KA, LI XW, SD MAVARAPU S et al.: Formul ai on of a mi cropati de cater for or polyplex-based DNA vanes Bicchim. Bicphys Ada (BBA)-albjeds(2004) 1674(2):149–157.
  • PAPANICOLAOU I, BRIGGS S, ALPAR HO: Increased reddaiceof DNA I poplexes to protein binding in vitro by ail-face-modification with a multivdent hydrophilic polymer. J. Drug Target. (2004) 12(8):541–547.
  • MUMPER RJ, WANG J, CLASPELL JM, ROLLAND AP: Novel polymeric condendng cat ers for gene del i very. Prccescl. Ccntrd. Relea.p Sm. (1995) 22:178–179.
  • ROY K, MAO HQ, HUANG SK, LEONG KW: Or genedelivery with chitosat-D NA naiopatidesgenerates immunologic protection in a murine model of peenut dlergy. Nat. Med. (1999) 5(4):387–391.
  • JANES KA, CALVO P, ALONSO MJ: Fblysaochai de colloi dd patidesasdelivery sydemsfor macromolecules Adv. Drug Deliver. Rat. (2001)47(l):83–97.
  • ROMOREN K, THU BJ, EVENSEN O: Expression of ludferase in selected orgais following delivery of nd ecl aid formulded DNA to rdnbow trout (Onccrhynchus m*i sd by different routes of administration. Fit] apellfith I mmundcgy (2004) 16(2):251–264.
  • FYNAN EF, WEBSTER RG, FULLER DH, HAYNES JR, SANTORO JC, ROBINSON HL: DNA Vapci nes protective i mmunizdions by paenterd, mucosel, aid gene-gun inoculations Froa Natl. Acad. ai. USA (1993) 90(24):11478–11482.
  • ••A semind pdper in D NA vaxi nediscovery;ab edendve aid interesting compaative study, compaing routes of administration aid protective efficacy agdnst lethd nfluenza chd lenge in chickens aid mice.
  • HAN R, REED CA, CLADEL NM, CHRISTENSEN ND: Immunization of rdobitswith cottontdl rdobit papillomavirus El aid E2 genes protective immunity induced by gene gun-medi ded ntracutageous del i very but not by intranus:ula injection. Vaccine (2000) 18(26):2937–2944.
  • FELTQUATE DM, HEANEY S, WEBSTER RG, ROBINSON HL: Different T helper cell typesaid alibody imtypes generated by selinead gene gun DNA immunization. J. I mmund. (1997) 158(5):2278–2284.
  • KEAN T, ROTH S, THANOU M: Trimethylded chi toseris as non-vi rd gene del i very vectors cytotoxicity aid traisfecti on efficiency. J Ccntrd. Relea.%(2005) 103(3):643–653.
  • DOUGLAS KL, TABRIZIAN M: Effect of experimentd paaneters on the formation of dg nate-chi tosen naiopati d es aid evdudion of their potentid Tplication ffi DNA cater. J Bicmate-. i. Rdyrn. Ed. (2005) 16(1):43–56.
  • RAMOS EA, RELUCIO JL, TORRES-VILLANUEVA CA: Gene expression in TilTiafollowing ord delivery of chi toseri-encepailated plaemid DNA incorporated into fit] feeds Mar. Bide:hnd. (NY) (2005)
  • PASNIK DJ, SMITH SA: Immunogenic aid protective effects of a DNA vaccine for Mycobacterium mainum in fit]. W. I mmund. I mmunop. (2005) 103(3-4):195–206.
  • YOO H, LEE J, CHUNG H, KWON I, JEONG S: Self-assembled naiopatidescontdning hydrophobi ally modified ycol chi tosen for gene del ivery. J Ccntrd. %ea.% (2005) 103(1):235–243.
  • MAYRHOFER P, TABRIZI CA, WALCHER P, HAIDINGER W, JECHLINGER W, LUBITZ W: Immobilization of plasmid DNA in bacterid ghods J Ccntrd. Release (2005) 102(3):725–735.
  • LODE HN, HUEBENER NI, ZENG YA, FEST ST, GAEDICKE GE: DNA mi ni gene vacci nation for adjuval neurobl astoma therapy. Ann. NY Acad. S:i. (2004) 1028(1):113–121.
  • SCHOEN C, STRITZKER J, GOEBEL W, PILGRIM S: BacteriaffiD NA vaxi ne cat ersfor genetic immunization. I nt J. MEd. Micrcbid. (2004) 294(5):319–335.
  • XU F, ULMER JB: Attenuaed selmonella aid Sligellaascariersfor DNA vanes J. Drug Target. (2003) 11(8-10):481–488.
  • DIETRICH G, KOLB-MAURER A, SIRENG S, SCHARTL M, GOEBEL W, GENTSCH EV I: Gran-padtivead Gran-negative bacteri a as cat er systems for DNA vaxi nes Vacci ne (2001) 19(17-19):2506–2512.
  • DIETRICH G, EV I, KNAPP B, KAUFMANN SH, GOEBEL W: From evil to good: a cytolydn in vaocinedevelopment. Trends M crcipi d (2001) 9(1):23–28.
  • SHATA MT, STEVCEVA L, AGWALE S, LEWIS GK, HONE DM: Recent advaices with recombi nait bacteria vacci ne vect ors Md. MEd. Today (2000) 6(2):66–71.
  • STOCKER BA: Aromaic-dependent Sa monella asali-bacteria vaccinesaid as presenters of hffologousa1tige1s or of DNA encoding them. J Biote:hnd. (2000) 83(1-2):45–50.
  • GUO H, LIU Z, SUN S et al.: Immune reEponin gui nea pigs vaoci naed with DNA vacci ne of foot-aid-mouth di same virus 0/Chi na99. Vacci ne (2005) 23(25):3236–3242.
  • QU B, ROSENBERG RN, LI L, BOYER PJ, JOHNSTON SA: Gene vaxinaion to biffitheimmune reEpon to a-nyi oid-beta pepti de ffi therapy for Altieimer'sdiseae. Arch. NEurd. (2004) 61(12):1859–1864.
  • SHI HZ: DNA vaccinead asthma therapy. Chin. MEd. d (2005) 118(7):531–533.
  • HAGAN DT, SINGH M, DONG C Et al.: Cationic micropa-tidesa-e a potent delivery syclem for a H CV DNA vaxine Vacci ne (2004) 23(5):672–680.
  • •Cationic aid alionicaly modified micropatides have been extendvely invedigated by this group; other publicationsfrom 0' H agen Et al. may be of interest to the reader.
  • GURUNATHAN S, KLINMAN DM, SEDER RA: DNA Vaocines immunology, application, aid optimization. Ann. Rat. I mmund . (2000) 18(1):927–974.
  • STEVENSON FK, OTTENSMEIER CH, JOHNSON P et al.: DNA vaxinesto atack cencer. Roc Natl. Acad. Sci. USA (2004) 101(SJppl. 2):14646–14652.
  • LEITNER WW: Myth, menaceor medica blessing?Thedinicel potentia aid the probl EMS of genetic vaccines EM BO I. (2001) 2(3):168–170.
  • LEGENDRE D, FASTREZ J: Roduction in SacchacrnyzEs ce-edidaeof Mvirus-likepatidespackagingfundiond heterologous mRN As Biote:hnd. (2005) 117(2):183–194.
  • MOORE AC, HILL AV: Prog-essin DNA-bad heterologous pri me-boost immunization straegiesfor maaia I mmund . Re/. (2004) 199(1):126–143.
  • WEBSTER DP, DUNACHIE S, VUOLA JM Et al.: Enhaiced T cell-mediated protection aganst maaiain humai cha lenges by ungtherombinait poxvi ruses FP9 aid modified vaoci ni a virusAnkaa Prcc Natl. Acad. S:i. USA (2005) 102(13):4836–4841.
  • CHATFIELD SN, ELL RA, DOUGAN G: LiveSalmcnellaas vacci nes aid cat ers of foreign aligenic determi naits Vaccine(1989) 7(6):495–498.
  • TAYLOR J, PAOLETTI E: Fbx virusesffi euka-yotic doning aid expression vectors future medi aid veteri nay vaoci nes R-cg V. Micrcipid. I mmund. (1988)4:197–217.
  • COHEN J: Public heath. Hii hopes aid dilemmffifor a cervica caliper vaocine Ence (2005) 308(5722):618–621.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.